SANTANDER UK GROUP HOLDINGS PLC / 2016 EMTN UPDATE
The following Prospectus has been approved by the UK Listing Authority and is available for viewing:
Prospectus dated 31 August 2016 relating to the €30,000,000,000 Euro Medium Term Note Programme of Santander UK Group Holdings plc.
To view the full Prospectus, or any of the documents referred to therein, please paste the appropriate URL from the following list into the address bar of your browser:
Santander UK Group Holdings plc Annual Report 2015
Santander UK Group Holdings plc Annual Report 2014
Santander UK Group Holdings plc Half Yearly Financial Report as at and for the six months ended 30 June 2016
The full Prospectus is also available for viewing at the National Storage Mechanism. This website is not provided for, nor is it directed at, U.S. persons or persons in the United States. If you are a U.S. person, or you are viewing this page from the United States, you should exit this section of the website.
For further information, please contact:
Medium Term Funding
Santander UK Group Holdings plc
2 Triton Square
London NW1 3AN
Tel: +44 (0) 20 7756 7107
Email: [email protected]
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
The Prospectus on this website does not constitute an offer of securities for sale in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold in, the United States of America, or to, or for the benefit of, U.S. persons (as defined in Regulation S of the Securities Act), unless the securities are registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.
This information is provided by RNS